Cognitive and behavioral radicalization: A systematic review of the putative risk and protective factors
Abstract
Abstract Background Two of the most central questions in radicalization research are, (1) why do some individuals radicalize when most of those from the same groups or exposed to similar conditions do not? and (2) why do radicalized individuals turn to radical violence while the majority remain inert? It has been suggested that the answer to both questions lie in the cumulative and interactive effects of a range of risk factors. While risk assessment and counter‐radicalization take a risk‐protective factor approach, there is widespread debate as to what these factors are and which are most important. Objectives This review has two primary objectives. 1) To identify what the putative risk and protective factors for different radicalization outcomes are, without any predeterminations. 2) To synthesize the evidence and identify the relative magnitude of the effects of different factors. The review's secondary objectives are to: 1) Identify consistencies in the estimates of factors across different radicalization outcomes. 2) Identify whether any significant heterogeneity exists within factors between (a) geographic regions, and (b) strains of radicalizing ideologies. Search Methods Over 20 databases were searched for both published and gray literature. In order to provide a more comprehensive review, supplementary searches were conducted in two German and one Dutch database. Reference harvesting was conducted from previous reviews and contact was made with leading researchers…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.